The use of inhaled corticosteroids in pediatric asthma: Update

E. Hossny, N. Rosario, B.W. Lee, M. Singh, D. El-Ghoneimy, J.Y. Soh, Peter Le Souef

    Research output: Contribution to journalReview articlepeer-review

    48 Citations (Scopus)


    © 2016 Hossny et al.Despite the availability of several formulations of inhaled corticosteroids (ICS) and delivery devices for treatment of childhood asthma and despite the development of evidence-based guidelines, childhood asthma control remains suboptimal. Improving uptake of asthma management plans, both by families and practitioners, is needed. Adherence to daily ICS therapy is a key determinant of asthma control and this mandates that asthma education follow a repetitive pattern and involve literal explanation and physical demonstration of the optimal use of inhaler devices. The potential adverse effects of ICS need to be weighed against the benefit of these drugs to control persistent asthma especially that its safety profile is markedly better than oral glucocorticoids. This article reviews the key mechanisms of inhaled corticosteroid action; recommendations on dosage and therapeutic regimens; potential optimization of effectiveness by addressing inhaler technique and adherence to therapy; and updated knowledge on the real magnitude of adverse events.
    Original languageEnglish
    Article number26
    JournalWorld Allergy Organization Journal
    Issue number1
    Publication statusPublished - 12 Aug 2016


    Dive into the research topics of 'The use of inhaled corticosteroids in pediatric asthma: Update'. Together they form a unique fingerprint.

    Cite this